Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Dedicated

- PMLiVE

Lilly agrees two antibody deals

Signs agreements with Genmab and Arteaus Therapeutics

- PMLiVE

Merck shares jump on melanoma drug filing

MK-3475 could be approved by end of 2014

China flag thumb

Sinopharm executives face corruption probe in China

Two employees said to be detained for misappropriating company funds

- PMLiVE

New London head for comms firm JPA

Valerie Carter has experience at Merck & Co

- PMLiVE

GSK launches Facebook weight loss campaign for Alli

‘60-Day Kickstart’ initiative offers free healthy living support

- PMLiVE

ghg and OptimizeRx join forces on electronic health records

Will make use of data to support healthcare professionals

- PMLiVE

Peacock steps down as Amgen CFO

Michael Kelly appointed acting financial head

- PMLiVE

GSK ends muscular dystrophy deal

Terminates rare disease collaboration with Prosensa after trial disappointment

Daiichi Sankyo logo

Daiichi files new anticoagulant edoxaban in US and EU

Seeks approvals in atrial fibrillation and venous thromboembolism

Sanofi reception

Sanofi strikes $700m rare diseases deal

Company's Genzyme division will obtain significant rights to Alnylam’s pipeline of orphan drugs

UK faces ‘mountain high’ barriers to mHealth adoption

Doesn't help that industry shorthand is little understood by consumers

- PMLiVE

Novartis cancer chief Hoppenot leaves for top job at Incyte

He ends 10-year spell at Swiss pharma giant

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links